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Rapid development of antibody-based therapeutics are crucial to the agenda of
innovative manufacturing of macromolecular therapies to combat emergent diseases.
Although highly specific, antibody therapies are costly to produce. Molecularly imprinted
polymers (MIPs) constitute a rapidly-evolving class of antigen-recognition materials
that act as synthetic antibodies. We report here on the virus neutralizing capacity of
hydrogel-based MIPs. We produced MIPs using porcine reproductive and respiratory
syndrome virus (PRRSV-1), as a model mammalian virus. Assays were performed to
evaluate the specificity of virus neutralization, the effect of incubation time and MIP
concentration. Polyacrylamide and N-hydroxymethylacrylamide based MIPs produced
a highly significant reduction in infectious viral titer recovered after treatment, reducing
it to the limit of detection of the assay. MIP specificity was tested by comparing their
neutralizing effects on PRRSV-1 to the effects on the unrelated bovine viral diarrhea
virus-1; no significant cross-reactivity was observed. The MIPs demonstrated effective
virus neutralization in just 2.5min and their effect was concentration dependent. These
data support the further evaluation of MIPs as synthetic antibodies as a novel approach
to the treatment of viral infection.
Keywords: molecularly imprinted polymer, virus, porcine reproductive and respiratory syndrome virus,
neutralization, synthetic antibody mimic
INTRODUCTION
The complex interplay between the environment, the expanding human population and intensified
livestock production systems has led to an apparent increase in the frequency of emergence and
re-emergence of viral zoonoses. As demonstrated by the recent Ebola outbreak in West Africa,
there is potential for new and emerging viral infections to cause large epidemics with significant
mortality andmorbidity. Antibodies which neutralize viral infectivity are critical for immunological
protection and this may be exploited in the context of both passive and active immunization.
However, there is currently an unmet need to be able to rapidly and inexpensively produce
therapeutic antibodies for new/emergent viral diseases.
Molecularly imprinted polymers (MIPs), often referred to as synthetic antibodies, offer an
alternative approach to biomolecular and viral recognition. Molecular imprinting involves the
formation of a polymer comprising selective cavities based on amolecular or biomolecular template
(Mayes and Mosbach, 1997; Hawkins et al., 2005; Li et al., 2014). It has been demonstrated
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that polymerization of monomers in the presence of a molecular
target causes the formation of corresponding binding sites in
the resulting polymer. MIPs for binding small molecules have
been extensively researched and successfully commercialized for
the solid phase extraction of drugs and pesticides (Sánchez-
González et al., 2019) and sample clean-up and improvement
of chromatographic analysis (Regal et al., 2012). In recent years
there has been an increase in research activity to imprint larger
templates using water-based polymers realizing their application
for imprinting of more complex biologicals such as proteins
and viruses (Stevenson et al., 2016). To date, their potential
use has been almost entirely focused on bio-extraction/analysis
(Stevenson et al., 2016) and sensor applications (Saylan et al.,
2017). More recently, the MIP technology has been applied as a
novel nucleant for protein crystallization (Saridakis et al., 2011;
Reddy et al., 2012). The strategy relies on the MIP cavities
possessing complimentary chemical architecture allowing the
template biological to lock into the cavity.
The majority of papers published to date on virus imprinting
have been in the development of MIP-based virus diagnostics
and sensors (Hayden et al., 2003; Perozo et al., 2006; Malitesta
et al., 2012; Altintas et al., 2015; Malik et al., 2017; Ahmad et al.,
2019; Tancharoen et al., 2019). Typically, a surface stamping
method has been used to imprint for example tobacco mosaic
virus, parapoxvirus ovis, and human rhinovirus. The stamping
approach produces a thin film directly integrated with a sensor
such as electrochemical (Malitesta et al., 2012; Canfarotta et al.,
2018), optical (Ahmad et al., 2019), or acoustic (Hayden et al.,
2003; Uludag et al., 2007) devices resulting in a concentration
dependent signal upon selective binding of virus. Sankarakumar
and Tong (2013) performed the first study on the potential
antiviral use of MIPs. MIPs imprinted with bacteriophage fr were
able to reduce phage titers by approximately 1 log which was
significantly greater than the neutralization by non-imprinted
polymers (NIPs).
The aim of this study was to evaluate in vitro the antiviral
activity of MIPs imprinted with the porcine reproductive and
respiratory syndrome virus 1 (PRRSV-1) as a model mammalian
virus. PRRSV-1 is an enveloped RNA virus of the Arteriviridae
family (Kappes and Faaberg, 2015), which causes the most
economically important infectious disease affecting the global
pig industry (Holtkamp et al., 2013; Paz, 2015). PRRSV-1 was
also selected since it would allow direct follow-on experimental
studies to evaluate the safety and efficacy of MIPs in pigs, which
serve as an excellent large animal model.
The rationale behind selection of monomers for this study
was based on our previous experiences using acrylamide
and functionalized acrylamide monomers for protein
imprinting (Reddy et al., 2012; El-Sharif et al., 2014a,b,
2015). In our studies to date, we have demonstrated that
MIP binding affinity and selectivity for target protein
increases in the order N-isopropylacrylamide < acrylamide
< N-hydroxymethylacrylamide. This order also represents
increasing hydrophilicity and hydrogen bonding capability of
the monomer, which we understand to be the predominant
non-covalent interaction between template and monomer (El-
Sharif et al., 2014a,b). In extending the use of monomers to virus
imprinting, and based on hydrogen bonding interactions with
the hydrophilic envelope glycoproteins of the virus, we therefore
anticipated a similar order of imprinting capability. It should be
noted that cavity selectivity would be based on a combination of
virion shape but also intermolecular interactions between surface
proteins and hydrogen bonding functional groups (associated
with monomer) within the cavity.
MATERIALS AND METHODS
Virus Propagation, Purification and
Titration
PRRSV-1 subtype 1 Olot/91 strain was propagated in MARC-
145 cells (Mokhtar et al., 2014) and bovine viral diarrhea virus
(BVDV)-1a Oregon C24V strain propagated in fetal bovine
turbinate (FBT) cells as described previously (Riitho et al., 2017).
To produce purified PRRSV-1 virions for molecular
imprinting, virus propagation was performed in 850 cm2 roller
bottles (Thermo Fisher Scientific, Loughborough). Roller bottles
were seeded with 2.2 × 107 MARC-145 cells and incubated in a
roller incubator at 37◦C. As monolayers approached confluence,
the growth medium was replaced with PRRSV-1 Olot/91 virus
suspended in 50ml DMEMmedium supplemented with 1% FBS
at a multiplicity of infection of 0.1. Four days post-infection the
culture supernatant was collected, pooled with a freeze-thawed
cell lysate, clarified by centrifugation at 524 × g for 15min and
stored at −80◦C. PRRSV-1 virions were purified by continuous
density ultracentrifugation. Virus-containing supernatants
were further clarified by centrifugation at 4,700 rpm (TX-750
rotor, Beckman Coulter, High Wycombe, UK) at 4◦C for 1 h.
Polyethyleneglycol (PEG)-6000 (Sigma, Poole, UK) was slowly
added (7% w/v) under stirring, the mixture incubated at 4◦C
under slow continuous stirring overnight and precipitated virus
collected by centrifugation at 4,700 rpm (TX-750 rotor), 4◦C
for 30min. The precipitated virus pellet was resuspended in
7ml TNE buffer (20mM Tris HCl pH 8.0, 150mM NaCl, 2mM
EDTA) and incubated overnight at 4◦C. Insoluble material
was removed by centrifugation (4,700 rpm, 4◦C for 10min
in a TX-750 rotor). The resulting clarified viral supernatants
were pelleted through a sterile 30% sucrose in TNE buffer
cushion at 28,000 rpm for 4 h at 4◦C using a SW50.1 rotor and
XPN-100 Ultracentrifuge (Beckman Coulter). Virus pellets were
gently reconstituted in low volumes of TNE buffer before being
layered over tubes containing a continuous 15–45% sucrose
gradient prepared using a Gradient Master 108 (BioComp, New
Brunswick, Canada). Tubes were centrifuged at 28,000 rpm,
4◦C for 4 h using a SW50.1 rotor and XPN-100 Ultracentrifuge.
1.5ml fractions were collected and PRRSV-1 infectious titers
determined. Those containing the major part of infectious
virus were dialyzed into PBS using Slide-A-Lyzer
TM
Dialysis
Cassettes (Thermo Fisher). Infectious titers were confirmed
post-dialysis and virus was inactivated by incubation with 0.1%
β-propiolactone (Sigma).
Infectious titers were determined by log-fold serial dilution of
viruses, which were added to 96 well flat bottom tissue culture
plate containing MARC-145 or FBT cells (5 × 103 cells/well).
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The plates were incubated at 37◦C with 5% CO2 for 4 days.
Immunoperoxidase staining was performed to determine the
number of infected wells and allow calculation of themedian 50%
tissue culture infective does (TCID50; Finney, 1978). PRRSV-
1 was detected using N-protein specific mAb 1AC7 (Ingenasa,
Madrid, Spain) and BVDV-1 with the E2-specific mAb WB214
antibody (APHA Scientific, Addlestone, UK).
All work with infectious viruses was risk assessed and
conducted under biocontainment level 2 conditions.
Production and Evaluation of
Hydrogel-Based Molecularly Imprinted
Polymers (MIPs)
All monomer solutions and reagent solutions used including
MBAm crosslinker [2% (w/v) solution], TEMED catalyst [5%
(v/v) solution], and initiator, APS [10% (w/v) solution] were
prepared in MilliQ water.
Polyacrylamide (pAA) MIP was prepared by mixing 13.5 µL
of AA (40% (w/v) solution) with 30µL ofMBAm crosslinker. The
solution was then added to 50 µL of purified inactivated PRRSV-
1 Olot/91 in PBS (107.4 TCID50/ml) and 2.5 µL of MilliQ water
to give 107.1 TCID50/ml of virus template in monomer solution.
The solution was vortexed for 30 s, before the catalyst, TEMED (2
µL) and initiator, APS (2 µL) were added to give a final volume
of 100 µL. The solution was vortexed for a further 30 s and then
purged with nitrogen for 5min. Polymerization was allowed to
occur overnight at room temperature (∼22◦C).
Poly-N-hydroxymethylacrylamide (pNHMA)was prepared in
a similar fashion using 16 µL of NHMA [48% (w/v) solution]
as functional monomer, and 30 µL of MBAm crosslinker, which
was then added to 50 µL 107.4 TCID50 /ml of purified inactivated
PRRSV-1 Olot/91 in PBS. The solution was vortexed for 30
seconds. TEMED (2 µL) and initiator, APS (2 µL) were then
added to give a final volume of 100µL. The solution was vortexed
for a further 30 s and then purged with nitrogen for 5min and
polymerization allowed to occur and left overnight at room
temperature (∼22◦C).
Poly-N-isopropylacrylamide (pNIPAM) was prepared using
14 µL of NIPAM [60% (w/v) solution] as functional monomer,
and 30 µL of MBAm as crosslinker. The resulting solution was
then added to 50 µL of 107.4 TCID50/ml of purified inactivated
PRRSV-1 Olot/91 in PBS and 2 µL of MilliQ H2O. The solution
was vortexed for 30 s. TEMED (2 µL) and initiator, APS (2 µL)
were then added to give a final volume of 100 µL. The solution
was vortexed for a further 30 s and then purged with nitrogen for
5min and occurred overnight at room temperature (∼22◦C).
For all three MIP preparations, the molar ratio of monomer
to crosslinker was kept constant at 20:1. For every MIP hydrogel
created, a non-imprinted control polymer (NIP) was prepared
and conditioned in an identical manner, but in the absence of
template virus.
Following polymerization, hydrogels were then individually
granulated using a 35µm sieve and conditioned by washing
100mg of granulated gel with five 0.4mL volumes of MilliQ
H2O followed by elution of the template, using five 0.2mL
volumes of 10% (w/v):10% (v/v) SDS:acetic acid (pH 2.8) and
another five 0.4mL volume washes of MilliQ H2O to remove
any residual eluent, and finally with a further two washes with
PBS to condition the gels. Each wash step was achieved by
vortexing followed by a centrifugation for 3min at 2419× g. The
PBS conditioned hydrogels were then diluted 1:1 (w/v) in PBS
(150mM, pH 7.2± 0.2) and stored at room temperature for virus
neutralization study purposes.
Non-purified PRRSV-1 was diluted to 2 × 105 TCID50/50µl
and mixed with an equal volume of MIP or NIP suspension
and incubated at room temperature for 1 h with mixing every
5min. After incubation, the mixture was centrifuged at 1,500
× g to pellet the MIP/NIP. Twenty five microliter of the
resulting supernatant was removed and the infectious PRRSV
titer determined as described above. The neutralizing capacity of
PRRSV-1 imprinted MIPs was also similarly tested on BVDV-
1. An experiment was additionally performed by varying the
incubation time of the virus with the MIP, from 1 h to 30, 15, 7.5,
5, 2.5, and 1.5min. The effect of varying the concentration of the
MIPs was tested by performing a serial 1:3 dilution of the MIPs
in PBS prior to incubation with virus.
Electron Microscopy (EM)
Virus suspensions post-dialysis and post-inactivation were
prepared for negative stain electron microscopy as follows. Seven
microliters of each sample were incubated at room temperature
on glow discharged, Formvar coated EM grids (Agar Scientific,
Stansted, UK) for 2min. Excess sample was gently removed and
following a brief water wash, grids were placed onto 3% aqueous
uranyl acetate (Agar Scientific, Stansted, UK) droplets for 1min.
Excess uranyl acetate was removed and grids were allowed to dry
before being imaged in a FEI T12 transmission EM at 100 kVwith
a Tietz F214 camera.
Statistical Methods
Data were graphically plotted and statistically analyzed
using GraphPad Prism v7.03 (GraphPad Software, La Jolla,
United States). A one-way ANOVA with Tukey’s multiple
comparisons tests was performed on log transformed infectious
viral titers. For assessment of the neutralizing capacity of
MIPs, mean data from 3 independent batches of MIPs were
compared. Datasets for other assays were technical replicates
within single experiments.
RESULTS
To produce a high quality template for this exploratory
study, PRRSV-1 virions were purified by density gradient
ultracentrifugation (Figures 1A–C). Whilst infectious virus was
detected in all sucrose gradient fractions, the highest titers were
detected, as predicted, in the central fractions of the gradient,
i.e., pools E and F (Figure 1A). Testing of the individual sucrose
gradient fractions confirmed the highest titers in fractions 16–
18 (Figure 1B) and these fractions were dialyzed into PBS and
inactivated prior to imprinting. Infectious virus titers post-
dialysis and post-inactivation were determined (data not shown)
and electron microscopy confirmed the structural integrity
of the template virus and the absence of significant cellular
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FIGURE 1 | Assessment of PRRSV-1 neutralization by virus-imprinted hydrogel MIPs. Template virus was prepared by purification of PRRSV-1 virions by continuous
density ultracentrifugation. Pools of gradient fractions (A) and individual fractions (B) containing the highest infectious titers were selected and virion purity and integrity
post-dialysis and inactivation confirmed by electron microscopy (C). Three independently produced batches of MIPs were tested for their ability to neutralize PRRSV-1
infectivity in vitro (D). A suspension of PRRSV-1 was incubated for 1 h with pAA, pNHMA or pNIPAM MIPs (closed bars). Non-imprinted polymers (NIPs; open bars)
and PBS (gray bars) were included as negative controls. Post-incubation, MIP/NIPs were removed by centrifugation and the infectious viral titers in supernatants
determined by immunoperoxidase staining of inoculated cell monolayers. The mean infectious PRRSV titers, expressed as 50% tissue culture infectious doses
(TCID50), for technical triplicates of each treatment condition are presented and error bars represent the standard error of the means. The limit-of-detection of the
assays are indicated by dashed horizontal lines.
debris (Figure 1C). Three separate assays were performed (each
in triplicate) to assess the PRRSV-1 neutralizing properties
of independently produced batches of MIPs, all imprinted
with purified PRRSV-1 virions (Figure 1D). Each of the MIPs
(pAA, pNHMA, and pNIPAM) were tested alongside their
corresponding NIP. A PBS control treatment was used as
a further negative control in each assay. Both pAA MIP
and pNHMA MIP produced a highly significant reduction in
infectious titer of PRRSV-1 (p < 0.0001) when compared with
their respective NIPs and the PBS control, both reducing the
infectious titer to the point of or below the limit-of-detection
(LoD) of the assay. The titers of virus recovered from pAA NIP
and pNHMANIP treatments were statistically comparable to the
PBS control treatment. There was no inter-batch variation in this
effect suggesting a reproducible imprinting-related neutralization
of virus. However, pNIPAM produced a very similar reduction in
infectious viral titer in both its MIP and NIP forms, suggesting
that molecular imprinting was not entirely responsible for the
neutralization event in the case of this polymer.
The specific binding capacity of the pAA and pNHMA
MIPs (both imprinted with PRRSV-1) was tested by comparing
their neutralizing effects on PRRSV-1 to the effects on BVDV-
1 (Figure 2A). Neither pAA MIP nor pNHMA MIP showed
significant reduction in BVDV-1 infectious viral titer. pNHMA
imprinted with PRRSV-1 was selected for an assay evaluating
the effect of decreasing incubation time on the neutralizing
capacity of the MIP on PRRSV-1 virus (Figure 2B). Significant
reduction in infectious viral titer to the assay LoD (p< 0.001) was
demonstrated at 60, 30, 15, 7.5, 5, and 2.5min incubation time,
with no significant differences in effect between the different
incubation times. A 1.5min incubation time caused a significant
(p < 0.05), but far less pronounced reduction in infectious
titer. With a view to assessing the binding capacity of virus-
imprintedMIPs, pAA and pNHMAwere selected for a trial of the
effect of decreasing MIP concentration on neutralizing capacity
(Figure 2C). Both MIPs showed a broadly similar effect with
decreasing concentration, providing complete neutralization of
infectious virus to the LoD of the assay at both neat and 1:5
dilutions. Lower concentrations ofMIP showed a dose dependent
reduction in neutralizing effect, which was more pronounced
with the pAAMIP.
DISCUSSION
This is the first study to demonstrate that MIPs imprinted with a
clinically relevant virus can exert potent antiviral effects, reducing
the infectious viral titer recovered to below the LoD of the assay
used. Both pAA and pNHMA MIP imprinted with PRRSV-1
were consistently able to neutralize a high quantity of infectious
PRRSV-1 (> 4 log reduction). A lack of neutralizing effect on
BVDV-1 suggests that a specific binding interaction is taking
place between the target molecule (virus, in this case PRRSV-1)
and the MIP. The concentration and time dependent effect of
neutralization further supports a rapid and specific binding. That
there was no discernible difference in the neutralization capacity
between pNIPAM MIP and NIP is interesting and suggests an
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FIGURE 2 | Characterization of the virus neutralizing properties of hydrogel MIPs. The specificity of PRRSV-1 virus-imprinted MIPs was assessed by evaluating
neutralization of BVDV-1 (A). A suspension of BVDV-1 was incubated for 1 h with pAA or pNHMA MIPs (closed bars). Non-imprinted polymers (NIPs; open bars) and
PBS (gray bars) were included as negative controls. To assess the effect of incubation time on PRRSV-1 neutralization by MIPs, a suspension of PRRSV-1 was
incubated for 60, 30, 15, 7.5, 5, 2.5, and 1.5min with pNHMA MIPs (closed bars) (B). Sixty minute incubation with NIPs (open bar) and PBS (gray bar) were included
as negative controls. To assess the effect of MIP concentration PRRSV-1 neutralization by MIPs, a suspension of PRRSV-1 was incubated for 1 h with a 5-fold serial
dilution of pAA or pNHMA MIPs, a neat suspension of NIPs or PBS (C). After incubation, MIPs/NIPs were removed and the infectious viral titers in supernatants
determined by immunoperoxidase staining of inoculated cell monolayers. The mean infectious titers, expressed as 50% tissue culture infectious doses (TCID50), for
technical triplicates of each treatment condition are presented and error bars represent the standard error of the means. The limit-of-detection of the assays are
indicated by horizontal dashed lines.
alternative non-specific mechanism for virus neutralization. We
have shown previously with protein imprinting that pNIPAM
is unable to demonstrate selective protein rebinding in either
the MIP or NIP form (Reddy et al., 2012). That there is a
virus neutralization event in this study, regardless of imprinting
taking place, points to the potential toxic nature of pNIPAM.
Alternatively, pNIPAM MIPs and NIPs may behave the same
because they both hydrophobically bind the viruses. It has been
established in this study with an animal virus and by others with
bacteriophages (Sankarakumar and Tong, 2013; Li et al., 2017)
that MIPs can successfully bind and neutralize viruses under
in vitro conditions. Whereas we have demonstrated complete
neutralization of PRRSV-1 (> 4 log reduction in titer) with a
single MIP dose, in contrast, in the bacteriophage studies, it
was observed, that a single dose of MIP was not sufficient to
completely neutralize viral infection (∼1 log reduction in titer
at best).
The results of our incubation time trial showing that complete
neutralization could be achieved in as little as 2.5min, is very
promising from the perspective of clinical application. However,
this would need to be re-assessed in the context of plasma
proteins and other potentially interfering molecules that would
be present in vivo. In terms of suitability for in vivo testing,
further work is needed to ensure suitable biocompatibility of
our MIPs. Li et al. (2017) produced dopamine-based MIPs
that showed no significant cytotoxicity on human hepatoma
cells (Li et al., 2017) but of particular relevance, was the
successful systemic application of acrylamide-based MIPs, to
mice without notable adverse effects (Hoshino et al., 2010). The
latter demonstrated the ability of MIPs to bind the cytotoxic
peptide melittin, the principle component of bee venom, in the
bloodstream of mice, which significantly reduced the mortality
and morbidity associated with melittin envenomation.
The data from this study has demonstrated a highly
effective and specific neutralization of virus infectivity
with certain hydrogel-based MIPs. Whilst promising, it is
possible that the destructive method used to produce these
cavity-containing hydrogel-MIPs leads to the majority of
the material comprising redundant unselective particles,
devoid of template-specific cavities. Further studies will
evaluate virus imprinting of nanoparticle-based MIPs
(nanoMIPs) for the efficient production of high bioaffinity
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materials (Canfarotta et al., 2016; Xu et al., 2017). MIPs
imprinted with virions may be produced according to
a variety of methods, giving nanoscale shells with cavity
populated surfaces.
In conclusion, hydrogel-based MIPs are capable of specifically
neutralizing virus infectivity in vitro within a short enough
incubation time to be clinically relevant. The findings of this
study support the further evaluation ofMIPs as alternative, stable,
and economical “plastic” antibodies that could be used to treat
and prevent viral infections.
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